发明名称 |
Targeting rare human PCSK9 variants for cholesterol treatment |
摘要 |
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method. |
申请公布号 |
US8951523(B1) |
申请公布日期 |
2015.02.10 |
申请号 |
US201414228760 |
申请日期 |
2014.03.28 |
申请人 |
Kymab Limited |
发明人 |
Clube Jasper Rupert |
分类号 |
A61K39/395 |
主分类号 |
A61K39/395 |
代理机构 |
Nixon Peabody LLP |
代理人 |
Nixon Peabody LLP ;Resnick David S.;Karttunen Contarino Leena H. |
主权项 |
1. A method of reducing cholesterol level or maintaining previously reduced cholesterol level in a human in need thereof comprising
a. selecting a human comprising a nucleotide sequence encoding a proprotein convertase subtilisin/kexin type 9 (PSCK9) that comprises a C-terminal domain comprising a mutation I474V in SEQ ID NO: 1; and b. administering to said human an antibody or antibody fragment that specifically binds a PCSK9 amino acid sequence encoded by said nucleotide sequence comprised by the human, wherein the antibody comprises a VH domain derived from the recombination of a human VH gene segment, a human D gene segment, and a human JH segment, the human VH gene segment encoding the framework 1 of SEQ ID NO: 40; and wherein said human comprises a VH gene segment encoding the framework 1 of SEQ ID NO: 40. |
地址 |
Cambridge GB |